Company / Capital Expenditures
Natera, Inc. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$106.2M
FY2025
5-year range
$19.6M / $106.2M
FY2021-FY2025
Trend
+59.9%
vs FY2024
Sector context
#57 of 151
Health Care
What the data says
At $106M, Natera, Inc.'s capital expenditures ranks #57 of 151 in the Health Care sector. Capital Expenditures has increased for 3 consecutive years, from $20M in FY2022 to $106M in FY2025.
Based on SEC 10-K filings.
$106M in FY2025 with a 5-year CAGR of +93.8%.
Improved from $39M to $106M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +75.6%
- 5-Year CAGR
- +93.8%
- 10-Year CAGR
- -
Sector benchmark
#57 of 151 in Health CareTop 38% of 151This company $106.2M Sector average $271.7M
▼
-60.9% below sector average
Key checks
Key Insights
- Natera, Inc.'s capital expenditures has grown for 3 consecutive years.
- 5-year CAGR of +93.8%, indicating consistent growth.
- In FY2025, capital expenditures increased 59.9% year-over-year.
- Ranks #57 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $106.2M | +59.9% |
| FY2024 | $66.4M | +69.5% |
| FY2023 | $39.2M | +100.0% |
| FY2022 | $19.6M | -52.2% |
| FY2021 | $41.0M | +957.5% |
| FY2020 | $3.9M | -60.7% |
| FY2019 | $9.9M | +154.3% |
| FY2018 | $3.9M | -60.7% |
| FY2017 | $9.9M | -57.4% |
| FY2016 | $23.1M | +194.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026